<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Biotech on Lionel Blog</title><link>https://hybridego.github.io/tags/biotech/</link><description>Recent content in Biotech on Lionel Blog</description><generator>Hugo</generator><language>ko-KR</language><lastBuildDate>Wed, 01 Jul 2026 08:36:00 +0900</lastBuildDate><atom:link href="https://hybridego.github.io/tags/biotech/index.xml" rel="self" type="application/rss+xml"/><item><title>오늘의 주식 후보 노트: 헬스케어 순환매</title><link>https://hybridego.github.io/2026/07/01/stock-candidate-note-healthcare-rotation/</link><pubDate>Wed, 01 Jul 2026 08:36:00 +0900</pubDate><guid>https://hybridego.github.io/2026/07/01/stock-candidate-note-healthcare-rotation/</guid><description>&lt;h1 id="오늘의-주식-후보-노트-헬스케어-순환매"&gt;오늘의 주식 후보 노트: 헬스케어 순환매&lt;/h1&gt;
&lt;ul&gt;
&lt;li&gt;Current date: 2026-07-01&lt;/li&gt;
&lt;li&gt;Analysis target: 한국과 미국 주식 후보 6개&lt;/li&gt;
&lt;li&gt;Report mode: Candidate journal / public stock research notebook&lt;/li&gt;
&lt;li&gt;Data timestamp: 2026-07-01 08:36 KST 기준. 한국 시세는 네이버 모바일 종목 API의 2026-06-30 종가와 2026-07-01 장전 표시값, 미국 시세는 Nasdaq API의 2026-06-30 정규장 종가 기준&lt;/li&gt;
&lt;li&gt;주요 출처: &lt;a href="https://www.mk.co.kr/news/stock/12085898"&gt;매일경제 - 랠리 소외 바이오와 2차전지 급등&lt;/a&gt;, &lt;a href="https://www.nspna.com/report/?mode=view&amp;amp;newsid=818527"&gt;NSP통신 - 제약주 상승, 삼성바이오로직스와 셀트리온 강세&lt;/a&gt;, &lt;a href="https://en.sedaily.com/news/2026/06/01/celltrions-us-direct-sales-model-takes-hold-fueling-new"&gt;Seoul Economic Daily - Celltrion U.S. direct sales&lt;/a&gt;, &lt;a href="https://www.thelec.net/news/articleView.html?idxno=10903"&gt;The Elec - biosimilar deregulation&lt;/a&gt;, &lt;a href="https://investor.lilly.com/news-releases/news-release-details/lilly-reports-first-quarter-2026-financial-results-raises-full"&gt;Eli Lilly 2026년 1분기 실적&lt;/a&gt;, &lt;a href="https://www.tikr.com/blog/eli-lillys-revenue-grew-56-in-q1-and-the-market-barely-blinked"&gt;TIKR - Eli Lilly Q1 summary&lt;/a&gt;, &lt;a href="https://api.nasdaq.com/api/quote/LLY/info?assetclass=stocks"&gt;Nasdaq LLY&lt;/a&gt;, &lt;a href="https://api.nasdaq.com/api/quote/JNJ/info?assetclass=stocks"&gt;Nasdaq JNJ&lt;/a&gt;, &lt;a href="https://api.nasdaq.com/api/quote/CAH/info?assetclass=stocks"&gt;Nasdaq CAH&lt;/a&gt;, &lt;a href="https://m.stock.naver.com/domestic/stock/068270"&gt;네이버 금융 셀트리온&lt;/a&gt;, &lt;a href="https://m.stock.naver.com/domestic/stock/207940"&gt;네이버 금융 삼성바이오로직스&lt;/a&gt;, &lt;a href="https://m.stock.naver.com/domestic/stock/196170"&gt;네이버 금융 알테오젠&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;blockquote&gt;
&lt;p&gt;이 글은 투자 추천이 아니라 공개자료로 남기는 후보 선별 기록이다. 무료 공개자료와 지연 시세를 썼고, 일부 미국 섹터 로테이션 수치는 기사 본문보다 검색 결과와 가격 API에 더 의존했다.&lt;/p&gt;</description></item></channel></rss>